Clinical trial
Integrated Prospective and Retrospective Observational Study to Characterize Biomarkers and Disease Progression in Patients With Pelizaeus-Merzbacher Disease
NCT05659901 is registered in ClinicalTrials.gov with Ionis Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Integrated Prospective and Retrospective Observational Study to Characterize Biomarkers and Disease Progression in Patients With Pelizaeus-Merzbacher Disease
- Lead sponsor
- Ionis Pharmaceuticals, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 3, 2022
- Completion date
- March 31, 2029
- Enrollment
- 32 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.